Real-time enrollment status for this myelodysplastic syndrome clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:07 AM UTC
| NCT Number | NCT06616636 |
| Recruiting Status | Recruiting |
| Condition | Myelodysplastic Syndrome |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 2 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT06616636 is currently recruiting participants. This phase1 study for myelodysplastic syndrome is actively seeking new participants at 2 locations across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06616636 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06616636 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.